Citation Impact
Citing Papers
Circulating CD21 low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells
2009
Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells
2004
Cell-Free HIV Type 1 Infection is Restricted in the Human Trophoblast Choriocarcinoma BeWo Cell Line, Even with Expression of CD4, CXCR4 and CCR5
2003 StandoutNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee
2020 Standout
Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development
2002
Nodal and splenic marginal zone B cell lymphomas
2005
CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus Infection
2008
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
2010 StandoutNobel
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
Regulation of IgA synthesis at mucosal surfaces
2004 StandoutNobel
Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia
2006
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
2010 StandoutNobel
Role of AID in Tumorigenesis
2007 StandoutNobel
Viruses and lymphoma/leukaemia
2005
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells
2005 StandoutNobel
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Upscaling of lentiviral vector production by tangential flow filtration
2005
Epstein-Barr virus: exploiting the immune system
2001 Standout
Immunopathology of multiple sclerosis
2015 Standout
Nasopharyngeal carcinoma
2015 Standout
Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma
2003
Immunity, Inflammation, and Cancer
2010 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
2019
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Epstein‐Barr virus (EBV)‐positive lymphoproliferations in post‐transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes
2003
B cells under influence: transformation of B cells by Epstein–Barr virus
2003
Infectious agents and lymphoma development: molecular and clinical aspects
2009
B cell–specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers
2009 StandoutNobel
Contrasting Roles of Dendritic Cells and B Cells in the Immune Control of Epstein-Barr Virus
2003
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
2007
The N276 Glycosylation Site Is Required for HIV-1 Neutralization by the CD4 Binding Site Specific HJ16 Monoclonal Antibody
2013
Contribution of the Epstein–Barr virus to the molecular pathogenesis of Hodgkin lymphoma
2007
Molecular biology of Hodgkin's lymphoma
2002
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
2012
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions
2007
The Expression Pattern of Epstein-Barr Virus Latent Genes In Vivo Is Dependent upon the Differentiation Stage of the Infected B Cell
2000
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Time-tagged ticker tapes for intracellular recordings
2023 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Epstein-Barr virus infection and human malignancies.
2001
Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34 + Cells with Epstein-Barr Virus
2004
UNC93B1 mediates differential trafficking of endosomal TLRs
2013 StandoutNobel
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Discriminating gene expression profiles of memory B cell subpopulations
2008
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase
2015 StandoutNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching
2003
Diminished Production of Human Immunodeficiency Virus Type 1 in Astrocytes Results from Inefficient Translation ofgag,env, andnefmRNAs despite Efficient Expression of Tat and Rev
1999
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells
2006
The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions
2014
Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils
2000
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cellsin vivo
2003
Survival and Clonal Expansion of Mutating “Forbidden” (Immunoglobulin Receptor–Deficient) Epstein-Barr Virus–Infected B Cells in Angioimmunoblastic T Cell Lymphoma
2001
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
The inhibitory potential of Fc receptor homolog 4 on memory B cells
2003
The Dispersal of Mucosal Memory B Cells
2002
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
2010
Epstein‐Barr virus infection and human malignancies
2001
Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells
2001
γ-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells
2002
Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells
2005
Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth
2006
Functional requirements of AID’s higher order structures and their interaction with RNA-binding proteins
2016 StandoutNobel
AID to overcome the limitations of genomic information
2005 StandoutNobel
Works of Julia Kurth being referenced
Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays
2008
EBV-Infected B Cells in Infectious Mononucleosis
2000
Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines
2002
EBV transformation overrides gene expression patterns of B cell differentiation stages
2008
Definition of the interacting interfaces of Apobec3G and HIV-1 Vif using MAPPIT mutagenesis analysis
2009
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT)
2003
Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation.
1999
Epstein–Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction
2003
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas
2005
In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice
1996
Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virus–infected cells and Epstein-Barr virus–harboring Hodgkin and Reed/Sternberg cells in Hodgkin disease
2000